StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.65−0.23 (-5.93%)

Close on Nov 17, 2026Market cap $525.20MP/E 24.8Yield –

Anbio Biotechnology total assets

Total assets on the balance sheet at the end of each period.

Anbio Biotechnology's total assets was $30.24M at Dec 31, 2025. For fiscal 2025 it was $30.24M, up 59.8% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$30.24M+59.8%
FY2024Dec 31, 2024$18.92M+19.7%
FY2023Dec 31, 2023$15.81M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$30.24M–
Q4 FY2024Dec 31, 2024$18.92M–
Q4 FY2023Dec 31, 2023$15.81M–

More Anbio Biotechnology figures

See a number that looks wrong?